期刊文献+

靶向CTNNB1的shRNA抑制结肠癌SW480细胞增殖的研究

ShRNA targeting against CTNNB1 inhibits growth of human colon cancer SW480 cells
原文传递
导出
摘要 目的探讨靶向CTNNB1的shRNA对人结肠癌SW480细胞的基因下调效应和细胞增殖的抑制作用。方法构建靶向CTNNB1的shRNA载体质粒,然后转染入结肠癌SW480细胞。用RT-PCR和Western blotting方法检测CTNNB1的mRNA和蛋白的表达情况。MTT实验评价转染后各组细胞的增殖情况,并用流式细胞仪检测各组细胞的周期分布和凋亡情况。结果靶向CTNNB1的shRNA能够明显下调CTNNB1 mRNA和蛋白质表达(P<0.05),其抑制率分别是43.87%和45.16%。MTT实验提示CTN组细胞在转染后呈现随着时间延长而进行性增殖抑制的现象。在转染后72h,CTN组的细胞存活率为46.4%,与空白对照组相比有显著性降低(P<0.05)。而流式细胞仪显示CTN组细胞有明显G0/G1周期阻滞和凋亡率增高(P<0.05)。结论靶向CTNNB1的特异性shRNA对结肠癌SW480细胞具有下调CTNNB1基因表达,促进细胞凋亡并且显著抑制细胞增殖的效应。 Objective To observe the inhibitory effect of CTNNB1 gene expression and cell proliferation of the human colon cancer cell line SW480 caused by CTNNB 1-targeted ShRNA. Methods The shRNA against CTNNB1 was constructed and transfected into SW480 cells. The down-regulations of CTNNB1 expres- sions were detected by RT-PCR and Western blotting analysis. The cell proliferation was determined by soft agar colony formation assay. The effect of these shRNAs on cell cycle distribution and apoptosis was examined by flow cytometry. Results The CTNNBI-shRNA efficiently suppressed the expression of CTNNB1 mRNA and pro- tein, P〈0.05. The expression inhibition rates were 43.87% and 45.16% at the mRNA and protein level respec- tively. The MTY assay indicated that the specific shRNA resulted in significant inhibition of cell growth on the culture plates on a time-dependent manner. Seventy-two hours after transfection, the cell viability of CTN group was 46.4%, which was of statistical significance when compared with that of blank control group, P〈0.05. More- over, the cancer cells showed significant G0/G1 arrest and increased apoptosis in the CTN group by flow cytome- try, P〈0.05. Conclusion The specific CTNNBI-shRNA may down-regulate the expression of CTNNB1 gene, increase apoptosis and inhibit the growth of SW480 cells.
出处 《中华普通外科学文献(电子版)》 2011年第2期12-15,共4页 Chinese Archives of General Surgery(Electronic Edition)
基金 广东省科技厅科研基金资助项目(2010B080701038)
关键词 CTNNB1 结肠癌 RNA干扰 SHRNA CTNNB1 Colon eancer RNA interferenee ShRNA
作者简介 通信作者:钟诗龙,Email:txzz2001@gmail.com
  • 相关文献

参考文献3

二级参考文献23

  • 1杨剑锋,陈森林,刘志红,张芸.乳腺癌组织中E-cadherin、β-catenin及cyclin D1表达的相关性研究[J].癌症,2004,23(7):799-802. 被引量:23
  • 2Hai-Tao Guan,Xing-Huan Xue,Zhi-Jun Dai,Xi-Jing Wang,Ang Li,Zhao-Yin Qin.Down-regulation of survivin expression by small interfering RNA induces pancreatic cancer cell apoptosis and enhances its radiosensitivity[J].World Journal of Gastroenterology,2006,12(18):2901-2907. 被引量:40
  • 3GERMANN U A.PASTAN I.GOTTESMAN M M.P-glycoproteins:mediators of multidrug resistance[J].Semin Cell Biol,1993,4(1):63-76.
  • 4CAPLEN N J,PARRISH S,IMANI F,et al.Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems[J].Proc Natl Acad Sci U S A,2001,98(17):9742-9747.
  • 5LIPARDI C,WEI Q,PATERSON B M.RNAi as random degradative PCR:siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNAs[J].Cell,2001,107(3):297-307.
  • 6VAN RENSBURG C E.JOONE G K.O'SULLIVAN J F.Clofazimine and B4121 sensitize an intrinsically resistant human colon cancer cell line to P-glycoprotein substrates[J].Oncol Rep,2000,7(1):193-195.
  • 7LI J,XU L Z,HE K L,et al.Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line[J].Breast Cancer Res,2001,3(4):253-263.
  • 8KOK J W,VELDMAN R J,KLAPPE K,et al.Differential expression of sphingolipids in MRP1 overexpressing HT29 cells[J].Int J Cancer,2000,87(2):172-178.
  • 9CELIUS T,GARBERG P,LUNDGREN B.Stable suppression of MDR1 gene expression and function by RNAi in Caco-2 cells[J].Biochem Biophys Res Commun,2004,324(1):365-371.
  • 10PICHLER A,ZELCER N,PRIOR J L,et al.In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein[J].Clin Cancer Res,2005,11(12):4487-4494.

共引文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部